373 related articles for article (PubMed ID: 25812756)
21. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
Losordo DW; Dimmeler S
Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
[No Abstract] [Full Text] [Related]
22. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia.
Morishita R; Makino H; Aoki M; Hashiya N; Yamasaki K; Azuma J; Taniyama Y; Sawa Y; Kaneda Y; Ogihara T
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):713-20. PubMed ID: 21183732
[TBL] [Abstract][Full Text] [Related]
23. Progenitor cell therapy in patients with critical limb ischemia without surgical options.
Sprengers RW; Lips DJ; Moll FL; Verhaar MC
Ann Surg; 2008 Mar; 247(3):411-20. PubMed ID: 18376183
[TBL] [Abstract][Full Text] [Related]
24. Impact of angiogenic therapy in the treatment of critical lower limb ischemia in an animal model.
Reis PE; de Carvalho LP; Yasumura E; da Silva FH; Garcia BC; Beutel A; Sacramento CB; Baptista-Silva JC; de Campos RR; Takiya CM; Borojevic R; Han SW
Vasc Endovascular Surg; 2014 Apr; 48(3):207-16. PubMed ID: 24399130
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for peripheral arterial disease.
Shimamura M; Nakagami H; Taniyama Y; Morishita R
Expert Opin Biol Ther; 2014 Aug; 14(8):1175-84. PubMed ID: 24766232
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) promote the effect of therapeutic angiogenesis in critical limb ischemia (CLI) of diabetic rats.
Zhang Q; Wang T; Wu X; Wang Y; Wu X; Zhou M; Li Z; Liu B; Zheng F; Sun X; Liu T
Biochem Biophys Res Commun; 2020 Nov; 532(2):231-238. PubMed ID: 32868074
[TBL] [Abstract][Full Text] [Related]
27. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
Teraa M; Sprengers RW; van der Graaf Y; Peters CE; Moll FL; Verhaar MC
Ann Surg; 2013 Dec; 258(6):922-9. PubMed ID: 23426345
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic angiogenesis: translating experimental concepts to medically relevant goals.
Emanueli C; Madeddu P
Vascul Pharmacol; 2006 Nov; 45(5):334-9. PubMed ID: 17008132
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial.
Powell RJ; Dormandy J; Simons M; Morishita R; Annex BH
Vasc Med; 2004 May; 9(3):193-8. PubMed ID: 15675184
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor overexpression does not enhance adipose stromal cell-induced protection on muscle damage in critical limb ischemia.
Olea FD; Locatelli P; Hnatiuk A; De Lorenzi A; Valdivieso L; Rocha E; RamÃrez R; Laguens R; Crottogini A
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):184-8. PubMed ID: 25414254
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials.
Hammer A; Steiner S
Vasa; 2013 Sep; 42(5):331-9. PubMed ID: 23989068
[TBL] [Abstract][Full Text] [Related]
33. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
[TBL] [Abstract][Full Text] [Related]
34. Stem cell therapy in PAD.
Sprengers RW; Moll FL; Verhaar MC
Eur J Vasc Endovasc Surg; 2010 Mar; 39 Suppl 1():S38-43. PubMed ID: 20153223
[TBL] [Abstract][Full Text] [Related]
35. Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia.
Hastings CL; Kelly HM; Murphy MJ; Barry FP; O'Brien FJ; Duffy GP
J Control Release; 2012 Jul; 161(1):73-80. PubMed ID: 22562065
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic angiogenesis in critical limb and myocardial ischemia.
Vale PR; Isner JM; Rosenfield K
J Interv Cardiol; 2001 Oct; 14(5):511-28. PubMed ID: 12053643
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia.
Cobellis G; Maione C; Botti C; Coppola A; Silvestroni A; Lillo S; Schiavone V; Molinari AM; Sica V
Cell Transplant; 2010; 19(11):1425-37. PubMed ID: 20587143
[TBL] [Abstract][Full Text] [Related]
39. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
40. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.
Bura A; Planat-Benard V; Bourin P; Silvestre JS; Gross F; Grolleau JL; Saint-Lebese B; Peyrafitte JA; Fleury S; Gadelorge M; Taurand M; Dupuis-Coronas S; Leobon B; Casteilla L
Cytotherapy; 2014 Feb; 16(2):245-57. PubMed ID: 24438903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
